Why a distinct medical stream is necessary to support patients using cannabis for medical purposes. Journal of Cannabis Research. 2023 – https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-023-00195-8

Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions. Cannabis and Cannabinoid Research. 2023 – https://www.liebertpub.com/doi/epdf/10.1089/can.2021.0156

Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review. The Canadian Journal of Psychiatry. 2023 – https://journals.sagepub.com/doi/full/10.1177/07067437231183525

Exploring medical cannabis use in individuals with a traumatic brain injury. Exploration of Medicine. 2023 – https://www.explorationpub.com/Journals/em/Article/1001150

Applying a cannabis impairment framework to medical cannabis patients. Medicinal Usage of Cannabis and Cannabinoids. Academic Press; 2023

Cannabidiol-Associated Hepatotoxicity: A Systematic Review and Meta-Analysis. Journal of Internal Medicine. 2023 – https://doi.org/10.1111/joim.13627

Are Younger Medical Cannabis Users at Risk? Comparing Patterns of Use and Mental Health in Younger and Older Medical Cannabis Dispensary Users. SCHOLINK Children and Teenagers. 2023 – http://www.scholink.org/ojs/index.php/ct/article/view/15802/6891

Factors Associated with Problematic Cannabis Use in a Sample of Medical Cannabis Dispensary Users. Psychiatry and Clinical Psychopharmacology. 2022 – DOI: 10.5152/pcp.2022.22358

Differences in those who prefer smoking cannabis to other consumption forms for mental health: what can be learned to promote safer methods of consumption? Cannabinoids and Mental Health Risks. 2022 – https://doi.org/10.1080/10550887.2022.2107332

A Clinical Framework for Assessing Cannabis-Related Impairment Risk. Frontiers in Psychiatry. 2022 – https://doi.org/10.3389/fpsyt.2022.883517

A Clinical Framework for Evaluating Cannabis Product Quality and Safety. Cannabis and Cannabinoids Research. 2022 – https://doi.org/10.1089/can.2021.0137

Rapid response to ‘Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline’. BMJ. 2021 – https://doi.org/10.1136/bmj.n2040

Narouze SN, MacCallum CA. eds. Cannabinoids and Pain. Springer; 2021

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process. Journal of Cannabis Research. 2021 – https://doi.org/10.1186/s42238-021-00073-1

Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations. European Journal of Internal Medicine. 2021 – https://doi.org/10.1016/j.ejim.2021.05.002

Practical strategies using medical cannabis to reduce harms associated with long term opioid use in chronic pain. Frontiers in Pharmacology. 2021 – https://doi.org/10.3389/fphar.2021.633168

Duration of neurocognitive impairment with medical cannabis use: a scoping review. Frontiers in Psychiatry. 2021 – https://doi.org/10.3389/fpsyt.2021.638962

Guidance in Authorizing Cannabis Products Within Primary Care © 2021 The College of Family Physicians of Canada

Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review. BMJ Open. 2020;10:e036114 – http://dx.doi.org/10.1136/bmjopen-2019-036114

Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments. BMC Psychiatry. 2019;19:335 – https://doi.org/10.1186/s12888-019-2324-z

Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine. 2018;49 – https://doi.org/10.1016/j.ejim.2018.01.004